Biocon chair Kiran Mazumdar-Shaw identifies successor as Indian pharma firm plans transition

Bicara Therapeutics

05/05/2026 07:29

May 5 (Reuters) - Biocon founder Kiran Mazumdar-Shaw plans a gradual leadership transition over the next five years, with her niece Claire Mazumdar expected to take over as chair in a phased manner, she told Reuters.

The succession plan was first reported by business magazine Fortune India in an interview with Mazumdar-Shaw.

(Reporting by Rishika Sadam; Writing by Surbhi Misra ; Editing by Nivedita Bhattacharjee)

((Surbhi.Misra@thomsonreuters.com |  X: https://twitter.com/SurbhiMisra_  |;))